242 related articles for article (PubMed ID: 16412233)
21. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S
Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516
[TBL] [Abstract][Full Text] [Related]
22. Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium.
Smith BA; Kennedy WJ; Harnden P; Selby PJ; Trejdosiewicz LK; Southgate J
Cancer Res; 2001 Feb; 61(4):1678-85. PubMed ID: 11245483
[TBL] [Abstract][Full Text] [Related]
23. Tissue structure, nuclear organization, and gene expression in normal and malignant breast.
Bissell MJ; Weaver VM; Lelièvre SA; Wang F; Petersen OW; Schmeichel KL
Cancer Res; 1999 Apr; 59(7 Suppl):1757-1763s; discussion 1763s-1764s. PubMed ID: 10197593
[TBL] [Abstract][Full Text] [Related]
24. Soft matrices inhibit cell proliferation and inactivate the fibrotic phenotype of deep endometriotic stromal cells in vitro.
Matsuzaki S; Canis M; Pouly JL; Darcha C
Hum Reprod; 2016 Mar; 31(3):541-53. PubMed ID: 26762314
[TBL] [Abstract][Full Text] [Related]
25. Rapid degradation of extracellular matrix proteins by normal human uroepithelial cells.
Allen LE; Dubeau L; Alvarez O; Jones PA
Cancer Res; 1990 Mar; 50(6):1897-904. PubMed ID: 2407347
[TBL] [Abstract][Full Text] [Related]
26. Type IV procollagen mRNA regulation: evidence for extracellular matrix/cytoskeleton/nuclear matrix interactions in human urothelium.
Schlussel RN; Droller MJ; Liu BC
J Urol; 1991 Aug; 146(2):428-32. PubMed ID: 1856949
[TBL] [Abstract][Full Text] [Related]
27. Screening candidate genes associated with bladder cancer using DNA microarray.
Xu A; Wang C; Sun S
Mol Med Rep; 2014 Dec; 10(6):3087-91. PubMed ID: 25323786
[TBL] [Abstract][Full Text] [Related]
28. Profiling the evolution of human metastatic bladder cancer.
Nicholson BE; Frierson HF; Conaway MR; Seraj JM; Harding MA; Hampton GM; Theodorescu D
Cancer Res; 2004 Nov; 64(21):7813-21. PubMed ID: 15520187
[TBL] [Abstract][Full Text] [Related]
29. Alteration of cell-cell and cell-matrix adhesion in urothelial cells: an oncogenic mechanism for mutant FGFR3.
di Martino E; Kelly G; Roulson JA; Knowles MA
Mol Cancer Res; 2015 Jan; 13(1):138-48. PubMed ID: 25223521
[TBL] [Abstract][Full Text] [Related]
30. Identification of gene expression patterns in superficial and invasive human bladder cancer.
Thykjaer T; Workman C; Kruhøffer M; Demtröder K; Wolf H; Andersen LD; Frederiksen CM; Knudsen S; Orntoft TF
Cancer Res; 2001 Mar; 61(6):2492-9. PubMed ID: 11289120
[TBL] [Abstract][Full Text] [Related]
31. Regulation of glioma cell phenotype in 3D matrices by hyaluronic acid.
Pedron S; Becka E; Harley BA
Biomaterials; 2013 Oct; 34(30):7408-17. PubMed ID: 23827186
[TBL] [Abstract][Full Text] [Related]
32. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.
Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI
BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362
[TBL] [Abstract][Full Text] [Related]
33. Transcriptome profiling and network pathway analysis of genes associated with invasive phenotype in oral cancer.
Kang CJ; Chen YJ; Liao CT; Wang HM; Chang JT; Lin CY; Lee LY; Wang TH; Yen TC; Shen CR; Chen IH; Chiu CC; Cheng AJ
Cancer Lett; 2009 Nov; 284(2):131-40. PubMed ID: 19457608
[TBL] [Abstract][Full Text] [Related]
34. [Screening and identification of heterogeneous phenotype-associated genes in human bladder cancer].
Yang YC; Li X; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):270-4. PubMed ID: 16546724
[TBL] [Abstract][Full Text] [Related]
35. Human melanocytes form a PAX3-expressing melanocyte cluster on Matrigel by the cell migration process.
Choi H; Jin SH; Han MH; Lee J; Ahn S; Seong M; Choi H; Han J; Cho EG; Lee TR; Noh M
J Dermatol Sci; 2014 Oct; 76(1):60-6. PubMed ID: 25128984
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-beta-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells.
Kirwan RP; Leonard MO; Murphy M; Clark AF; O'Brien CJ
Glia; 2005 Dec; 52(4):309-24. PubMed ID: 16078232
[TBL] [Abstract][Full Text] [Related]
37. Expression profiling of the influence of RAS mutants on the TGFB1-induced phenotype of the pancreatic cancer cell line PANC-1.
Fensterer H; Giehl K; Buchholz M; Ellenrieder V; Buck A; Kestler HA; Adler G; Gierschik P; Gress TM
Genes Chromosomes Cancer; 2004 Mar; 39(3):224-35. PubMed ID: 14732924
[TBL] [Abstract][Full Text] [Related]
38. Pathway-specific differences between tumor cell lines and normal and tumor tissue cells.
Ertel A; Verghese A; Byers SW; Ochs M; Tozeren A
Mol Cancer; 2006 Nov; 5(1):55. PubMed ID: 17081305
[TBL] [Abstract][Full Text] [Related]
39. Screening of differentially expressed genes related to bladder cancer and functional analysis with DNA microarray.
Huang YD; Shan W; Zeng L; Wu Y
Asian Pac J Cancer Prev; 2013; 14(8):4553-7. PubMed ID: 24083701
[TBL] [Abstract][Full Text] [Related]
40. Micro-array analysis of the effect of post-transurethral bladder tumor resection urine on transforming growth factor-beta1 dependent gene expression in transitional cell carcinoma.
Zhang G; Cao Y; Xu Y; See WA
Urol Oncol; 2005; 23(6):413-8. PubMed ID: 16301119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
